Biomimetic mri contrast agent for imaging of inflammation in atherosclerotic plaque of apoe-/- mice

Investigative Radiology

Volumn 44, Issue 3, 2009, Pages 151-158

  Alsaid, Hasan ^a,b,c,d   De Souza, Genevieve ^a,b,c,d   Bourdillon, Marie Claude ^a,b,e   Chaubet, Frédéric ^f,g   Sulaiman, Abdulrazzaq ^a,b,c,d   Desbleds Mansard, Catherine ^a,b,c,d   Chaabane, Linda ^a,b,c,d   Zahir, Charaf ^f,g   Lancelot, Eric ^g   Rousseaux, Olivier ^g   Corot, Claire ^g   Douek, Philippe ^a,b,c,d   Briguet, Andre ^a,b,c,d   Letourneur, Didier ^f,g   Canet Soulas, Emmanuelle ^a,b,c,d  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CNRS   (France)

^d CPE LYON   (France)

^e INSERM   (France)

^f UNIVERSITÉ PARIS 13   (France)

^g Laboratoire Guerbet   (France)

Author keywords

Apolipoprotein E knockout mice; Atherosclerotic plaque; Biomimetic contrast agent; Inflammation; Magnetic resonance imaging

Indexed keywords

APOLIPOPROTEIN E; CONTRAST MEDIUM; F P 717; P 717; PADGEM PROTEIN; UNCLASSIFIED DRUG;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; BIOMIMETICS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 67651108827     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e31819472ac     Document Type: Article

References (49)

1. Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA. 2003;290:932-940.
2. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
3. Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory biomarkers in acute coronary syndromes, part I: introduction and cytokines. Circulation. 2006; 113:72-75.
4. Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory biomarkers in acute coronary syndromes, part IV: matrix metalloproteinases and biomarkers of platelet activation. Circulation. 2006;113:e382-e385.
5. Kerwin W, Hooker A, Spilker M, et al. Quantitative magnetic resonance © 2009 Lippincott Williams & Wilkins imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation. 2003;107:851-856.
6. Choudhury RP, Fuster V, Badimon JJ, et al. MRI and characterization of atherosclerotic plaque: emerging applications and molecular imaging. Arte- rioscler Thromb Vasc Biol. 2002;22:1065-1074.
7. Chaabane L, Pellet N, Bourdillon MC, et al. Contrast enhancement in atherosclerosis development in a mouse model: in vivo results at 2 Tesla. MAGMA. 2004;17:188-195.
8. Flacke S, Fischer S, Scott MJ, et al. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation. 2001;104:1280-1285.
9. Davies MJ, Richardson PD, Woolf N, et al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J. 1993;69:377-381.
10. Hyafil F, Laissy JP, Mazighi M, et al. Ferumoxtran-10-enhanced MRI of the hypercholesterolemic rabbit aorta: relationship between signal loss and macrophage infiltration. Arterioscler Thromb Vasc Biol. 2006;26:176-181.
11. KooiME, CappendijkVC, CleutjensKB, etal.Accumulationofultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation. 2003; 107:2453-2458.
12. Ruehm SG, Corot C, Vogt P, et al. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation. 2001;103:415-422.
13. Amirbekian V, Lipinski MJ, Briley-Saebo KC, et al. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc Natl Acad Sci USA. 2007;104:961-966.
14. NahrendorfM, Jaffer FA, Kelly KA, et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation. 2006;114:1504-15011.
15. Tsourkas A, Shinde-Patil VR, Kelly KA, et al. In vivo imaging of activated endothelium using an anti-VCAM-1 magnetooptical probe. Bioconjug Chem. 2005;16:576-581.
16. Kang HW, Josephson L, Petrovsky A, et al. Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. Bioconjug Chem. 2002;13:122-127.
17. Winter PM, Morawski AM, Caruthers SD, et al. Molecular imaging of angiogenesis in early stage atherosclerosis with alpha (v) beta3- integrintargeted nanoparticles. Circulation. 2003;108:2270-2274.
18. Dong ZM, Chapman SM, Brown AA, et al. The combined role of P- and E-selectins in atherosclerosis. JClin Invest. 1998;102:145-152.
19. Bourdillon MC, Randon J, Barek L, et al. Reduced atherosclerotic lesion size in p-selectin deficient apolipoprotein e-knockout mice fed a chow but not a fat diet. JBiomedBiotechnol. 2006;2006:49193.
20. Brandley BK, Kiso M, Abbas S, et al. Structure-function studies on selectin carbohydrate ligands. Modifications to fucose, sialic acid, and sulphate as a sialic acid replacement. Glycobiology. 1993;3:633-641.
21. Chaubet F, Bertholon I, Serfaty JM, et al. A new macromolecular paramagnetic MR contrast agent binds to activated human platelets. Contrast Media Mol Imaging. 2007;2:178-188.
22. Corot C, Schaefer M, Beaute S, et al. Physical, chemical, and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer. Acta Radiol Suppl. 1997;412:91-99.
23. Corot C, Violas X, Robert P, et al. Pharmacokinetics of three gadolinium chelates with different molecular sizes shortly after intravenous injection in rabbits: relevance to MR angiography. Invest Radiol. 2000;35:213-218.
24. Bourasset F, Dencausse A, Bourrinet P, et al. Comparison of plasma and peritoneal concentrations of various categories of MRI blood pool agents in a murine experimental pharmacokinetic model. MAGMA. 2001;12:82-87.
25. Napoli C, Palinski W, Di MG, et al. Determination of atherogenesis in apolipoprotein E-knockout mice. Nutr Metab Cardiovasc Dis. 2000;10:209- 215.
26. Chaabane L, Soulas EC, Contard F, et al. High-resolution magnetic resonance imaging at 2 Tesla: potential for atherosclerotic lesions exploration in the apolipoprotein E knockout mouse. Invest Radiol. 2003;38:532-538.
27. Mansard CD, Canet Soulas EP, Anwander A, et al. Quantification of multicontrast vascular MR images with NLSnake, an active contour model: in vitro validation and in vivo evaluation. Magn Reson Med. 2004;51:370-379.
28. Corot C, Violas X, Robert P, et al. Comparison of different types of blood pool agents (P792, MS325, USPIO) in a rabbit MR angiography-like protocol. Invest Radiol. 2003;38:311-319.
29. Sirol M, Itskovich VV, Mani V, et al. Lipid-rich atherosclerotic plaques 157detected by gadofluorine-enhanced in vivo magnetic resonance imaging. Circulation. 2004;109:2890-2896.
30. Zheng J, Ochoa E, Misselwitz B, et al. Targeted contrast agent helps to monitor advanced plaque during progression: a magnetic resonance imaging study in rabbits. Invest Radiol. 2008;43:49-55.
31. Morawski AM, Winter PM, Crowder KC, et al. Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. Magn Reson Med. 2004;51:480-486.
32. Lanza GM, Winter PM, Caruthers SD, et al. Magnetic resonance molecular imaging with nanoparticles. JNucl Cardiol. 2004;11:733-743.
33. Hockings PD, Roberts T, Galloway GJ, et al. Repeated three-dimensional magnetic resonance imaging of atherosclerosis development in innominate arteries of low-density lipoprotein receptor-knockout mice. Circulation. 2002;106:1716-17121.
34. Itskovich VV, Choudhury RP, Aguinaldo JG, et al. Characterization of aortic root atherosclerosis in ApoE knockout mice: high-resolution in vivo and ex vivo MRM with histological correlation. Magn Reson Med. 2003;49:381-385.
35. Wiesmann F, Szimtenings M, Frydrychowicz A, et al. High-resolution MRI with cardiac and respiratory gating allows for accurate in vivo atherosclerotic plaque visualization in the murine aortic arch. Magn Reson Med. 2003;50:69-74.
36. McFadden EP, Chaabane L, Contard F, et al. In vivo magnetic resonance imaging of large spontaneous aortic aneurysms in old apolipoprotein E-defi-cient mice. Invest Radiol. 2004;39:585-590.
37. Tangirala RK, Rubin EM, Palinski W. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res. 1995;36:2320-2328.
38. Li G, Sanders JM, Phan ET, et al. Arterial macrophages and regenerating endothelial cells express P-selectin in atherosclerosis-prone apolipoprotein E-deficient mice. Am J Pathol. 2005;167:1511-1518.
39. Anderson SA, Rader RK, Westlin WF, et al. Magnetic resonance contrast enhancement of neovasculature with alpha(v) beta(3)-targeted nanoparticles. Magn Reson Med. 2000;44:433-439.
40. Anastase-Ravion S, Carreno MP, Blondin C, et al. Heparin-like polymers modulate proinflammatory cytokine production by lipopolysaccharide-stim-ulated human monocytes. JBiomed Mater Res. 2002;60:375-383.
41. Blondin C, Bataille I, Letourneur D. Polysaccharides for vascular cell targeting. Crit Rev Ther Drug Carrier Syst. 2000;17:327-375.
42. Deux JF, Meddahi-Pelle A, Le Blanche AF, et al. Low molecular weight fucoidan prevents neointimal hyperplasia in rabbit iliac artery in-stent reste-nosis model. Arterioscler Thromb Vasc Biol. 2002;22:1604-1609.
43. Deux JF, Prigent-Richard S, d'Angelo G, et al. A chemically modified dextran inhibits smooth muscle cell growth in vitro and intimal in stent hyperplasia in vivo. J Vasc Surg 2002;35:973-981.
44. Logeart D, Prigent-Richard S, Jozefonvicz J, et al. Fucans, sulfated polysac-charides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. comparison with heparin for antiproliferative activity, binding and internalization. Eur J Cell Biol. 1997;74:376-384.
45. Letourneur D, Caleb BL, Castellot JJ Jr. Heparin binding, internalization, and metabolism in vascular smooth muscle cells, I upregulation of heparin binding correlates with antiproliferative activity. J Cell Physiol. 1995;165: 676-686.
46. Phillips JW, Barringhaus KG, Sanders JM, et al. Single injection ofP-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient mice. Circulation. 2003;107:2244-2249.
47. May AE, Seizer P, Gawaz M. Platelets: inflammatory firebugs of vascular walls. Arterioscler Thromb Vasc Biol. 2008;28:s5-s10.
48. Canet-Soulas E, Letourneur D. Biomarkers of atherosclerosis and the potential ofMRI for the diagnosis ofvulnerable plaque. MAGMA. 2007;20:129-142.
49. Alsaid H, Sabbah M, Bendahmane Z, etal. High-resolutioncontrast-enhanced MRI of atherosclerosis with digital cardiac and respiratory gating in mice. Magn Reson Med. 2007;58:1157-1163.